
berkshir hathaway maintain sell
share teva last night morn news
berkshir hathaway brk rate purchas
share stock obvious news
come surpris us mani investor last fall sept
link announc mr schultz
appoint ceo upgrad share buy view
bring experienc pharma execut would posit
catalyst creat floor share item
occur share rise bottom
applaud mr schultz take aggress step restructur
lower oper cost think fundament within
co gener brand segment deterior
revenu base expect declin yoy debt-
to-ebitda ratio addit think investor
consid level deterior co gener
busi especi us someth
expect occur origin upgrad share
last fall recogn berkshir hathaway take
posit teva share could game chang event
investor sentiment perspect maintain sell
rate pt view path full-fledg recoveri
teva may take year heavi debt level
put co precari posit especi rise
base ebitda estim teva share
trade ev ebitda multipl estim
premium buy pt
closest competitor gener segment
recent approv momenta rate gener
mg copaxon pave way sandoz divis novarti
nv rate launch would expect sandoz grab
market share us within next month
current hold share gener version
valuat rate teva share sell pt
arriv via dcf analysi
pleas read import disclosur analyst certif appear appendix
btig cover compani mention report
appendix analyst certif import disclosur
timothi chiang herebi certifi view compani secur discuss report
accur express receiv receiv direct indirect compens exchang
express specif recommend view report
allison kelley herebi certifi view compani secur discuss report
accur express receiv receiv direct indirect compens exchang
express specif recommend view report
btig llc btig rate effect june defin follow
buy secur expect produc posit total return greater month
follow recommend buy rate may maintain long deem appropri
notwithstand price fluctuat would caus target fall outsid return
sell secur expect produc neg total return greater next month
follow recommend sell rate may maintain long deem appropri
notwithstand price fluctuat would caus target fall outsid return
neutral secur expect appreci depreci meaning next month
rate secur rate cover btig
review effect immedi coverag follow secur review rate price
target disclosur estim compani list suspend longer reli
